BioCentury | Apr 30, 2020
Management Tracks

Desmond-Hellmann joins GV as adviser; plus Radius, Anika, AMAG, AiCure and more

Susan Desmond-Hellmann joined VC firm GV as an adviser. She recently joined the board of Pfizer Inc. (NYSE:PFE) after stepping down as CEO of the Bill & Melinda Gates Foundation in December. Previously, she spent...
BioCentury | Mar 5, 2020
Emerging Company Profile

AiCure: harnessing AI to boost adherence

AiCure is combining a decade’s worth of research into real-world patient behavior with an artificial intelligence platform to optimize patient adherence to treatments in clinical trials. Lack of patient compliance to long-term treatments can lead...
BC Extra | Nov 9, 2019
Financial News

Nov. 8 Financial Quick Takes: First day of trading for BrightGene, Tot; plus argenx, Agios and AiCure

BrightGene shines in STAR debut   BrightGene Bio-Medical Technology Co. Ltd. (Shanghai:688166) gained RMB17.90 (141%) to RMB30.61 in its first day of trading on Shanghai’s STAR board. The company raised RMB521.1 million ($74.1 million) in...
Items per page:
1 - 3 of 3
BioCentury | Apr 30, 2020
Management Tracks

Desmond-Hellmann joins GV as adviser; plus Radius, Anika, AMAG, AiCure and more

Susan Desmond-Hellmann joined VC firm GV as an adviser. She recently joined the board of Pfizer Inc. (NYSE:PFE) after stepping down as CEO of the Bill & Melinda Gates Foundation in December. Previously, she spent...
BioCentury | Mar 5, 2020
Emerging Company Profile

AiCure: harnessing AI to boost adherence

AiCure is combining a decade’s worth of research into real-world patient behavior with an artificial intelligence platform to optimize patient adherence to treatments in clinical trials. Lack of patient compliance to long-term treatments can lead...
BC Extra | Nov 9, 2019
Financial News

Nov. 8 Financial Quick Takes: First day of trading for BrightGene, Tot; plus argenx, Agios and AiCure

BrightGene shines in STAR debut   BrightGene Bio-Medical Technology Co. Ltd. (Shanghai:688166) gained RMB17.90 (141%) to RMB30.61 in its first day of trading on Shanghai’s STAR board. The company raised RMB521.1 million ($74.1 million) in...
Items per page:
1 - 3 of 3